Sangamo Hemophilia B Trial Open - as of 10/12/16

Verify on  https://clinicaltrials.gov/

Ascending Dose Study of Genome Editing by the Zinc Finger Protein (ZFP) Therapeutic SB-FIX in Severe Hemophilia B

This study is currently recruiting participants. (see Contacts and Locations)

Verified October 2016 by Sangamo Biosciences

Sponsor:

Sangamo Biosciences

Information provided by (Responsible Party):

Sangamo Biosciences

ClinicalTrials.gov Identifier:

NCT02695160

First received: February 24, 2016

Last updated: October 12, 2016

Last verified: October 2016

History of Changes